Skip to main content

Table 2 Perioperative course and postoperative outcome

From: Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis

Variables MELD < 30 MELD ≥ 30
WG (n = 323) HG (n = 323) P WG (n = 88) HG (n = 35) P
Warm ischemia time (mins) 8.50 ± 3.82 13.02 ± 4.00  < 0.01 8.14 ± 3.29 14.57 ± 3.16  < 0.01
Cold ischemia time (hours) 3.37 ± 2.2 3.17 ± 1.21 0.137 3.39 ± 1.27 3.24 ± 3.44 0.801
Operation time (h) 8.22 ± 2.67 9.55 ± 2.01  < 0.01 8.12 ± 2.03 10.06 ± 3.2 0.002
ICU stays (days) 4.69 ± 2.51 5.24 ± 1.24  < 0.01 4.76 ± 1.55 5.17 ± 1.58 0.191
Postoperative hospital stays (days) 11.06 ± 3.78 12.38 ± 6.59  < 0.01 11.56 ± 4 15.51 ± 5.89 0.001
Intraoperative blood loss (mL) 746.16 ± 441.64 856.97 ± 351.36  < 0.01 864.77 ± 319.14 1240 ± 795.37 0.010
Blood transfusion (mL) 384.52 ± 238.28 442.11 ± 198.34 0.001 437.5 ± 205.84 717.14 ± 584.35 0.009
EAD (%) 4 (1.2%) 3 (0.9%) NS 1 (1.1%) 1 (2.9%) NS
PNF (%) 1 (0.3%) 0 (0.3%) NS 0 0 NS
Postoperative infection (%)a 18 (5.6%) 17 (5.3%) 0.862 12 (13.6%) 6 (17.1%) 0.620
Vascular complication (%)b 6 (1.9%) 20 (6.2%) 0.005 3 (3.4%) 2 (5.7%) 0.938
Biliary complications (%)c 8 (2.5%) 14 (4.3%) 0.193 3 (3.4%) 3 (8.6%) 0.462
Intra-abdominal bleeding (%) 11 (3.4%) 22 (6.8%) 0.049 6 (6.8%) 4 (11.4%) 0.632
Clavien–Dindo ≥ Grade 3 (%) 40 (12.4%) 52 (16.1%) 0.177 10 (11.4%) 9 (25.7%) 0.047
  1. EAD early allograft dysfunction, PNF primary nonfunction
  2. aPostoperative infection including lung infection, urinary tract infection, abdominal abscess, wound infection, peritonitis, and positive blood culture
  3. bVascular complication including embolization and/or stenosis of any of the hepatic arteries, portal veins, and inferior vena cava
  4. cBiliary complications including biliary stricture, biliary bleeding, or bile leakage